FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13506011000001109: Melatonin 2mg modified-release tablets 21 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
48517101000001114 Melatonin 2mg modified-release tablets 21 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
48517201000001119 Melatonin 2mg modified-release tablets 21 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

7 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Melatonin 2mg modified-release tablets 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets 21 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets 21 tablet Is pack of Melatonin 2mg modified-release tablets false Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets 21 tablet Has active ingredient Melatonin false Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets 21 tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets 21 tablet VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets 21 tablet Has VMP Melatonin 2mg modified-release tablets true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets 21 tablet Has specific active ingredient Melatonin true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets 21 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Circadin 2mg modified-release tablets (Lundbeck Ltd) 21 tablet Is a True Melatonin 2mg modified-release tablets 21 tablet Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lexon (UK) Ltd) 21 tablet Is a True Melatonin 2mg modified-release tablets 21 tablet Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Waymade Healthcare Plc) 21 tablet Is a True Melatonin 2mg modified-release tablets 21 tablet Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 21 tablet Is a True Melatonin 2mg modified-release tablets 21 tablet Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Sigma Pharmaceuticals Plc) 21 tablet Is a True Melatonin 2mg modified-release tablets 21 tablet Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Necessity Supplies Ltd) 21 tablet Is a True Melatonin 2mg modified-release tablets 21 tablet Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Doncaster Pharmaceuticals Ltd) 21 tablet Is a True Melatonin 2mg modified-release tablets 21 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start